# Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

> **NCT01319526** · — · TERMINATED · sponsor: **AIDS Malignancy Consortium** · enrollment: 1 (actual)

## Conditions studied

- Lymphoma
- Nonneoplastic Condition

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** RNA analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01319526
- **Lead sponsor:** AIDS Malignancy Consortium
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Parent protocol (SWOG S0816 / AMC-073) discontinued
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319526, "Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT01319526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*